These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

80 related items for PubMed ID: 21621418

  • 1. Significant association of antiphospholipid antibodies and TNF-alpha: marker of severe atherogenic profile of patients with type II diabetes mellitus without micro and/or macrovascular complications.
    Becarevic M, Seferovic J, Ignjatovic S, Singh S, Majkic-Singh N.
    Cytokine; 2011 Aug; 55(2):301-6. PubMed ID: 21621418
    [Abstract] [Full Text] [Related]

  • 2. The IgM isotype of anti-annexin A5 antibodies and multiple positivity of conventional antiphospholipid antibodies: increasing the number of clinical manifestations of primary antiphospholipid syndrome.
    Bećarević M, Stojanović L, Ignjatović S, Dopsaj V.
    Clin Rheumatol; 2016 May; 35(5):1361-5. PubMed ID: 26971791
    [Abstract] [Full Text] [Related]

  • 3. Deterioration of thromboses in primary antiphospholipid syndrome: TNF-alpha and anti-annexin A5 antibodies.
    Bećarević M, Ignjatović S, Majkić-Singh N.
    Clin Lab; 2012 May; 58(9-10):1079-84. PubMed ID: 23163128
    [Abstract] [Full Text] [Related]

  • 4. Prevalence of antiphospholipid antibodies is not different in Chilean diabetic patients and normal individuals.
    Palomo IG, Mujica VE, Alarcón ML, Pereira JG, Vásquez MR.
    J Diabetes Complications; 2005 May; 19(3):133-7. PubMed ID: 15866057
    [Abstract] [Full Text] [Related]

  • 5. IgM, but not IgA rheumatoid factor interferes with anti-cardiolipin and antiβ2 glycoprotein I measurements: a quantitative analysis.
    Lakos G, Teodorescu M.
    Lupus; 2011 May; 20(6):614-9. PubMed ID: 21436214
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. [Antibodies to phospholipids and the vascular endothelium in nodular polyarteritis].
    Kirdianov SIu, Baranov AA, Nasonov EL, Salozhin KV, Gur'eva MS, Abaĭtova NE, Bazhina OV.
    Klin Med (Mosk); 2001 May; 79(5):32-6. PubMed ID: 11510182
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Evaluation of three commercial ELISA kits for anticardiolipin and anti-beta2-glycoprotein I antibodies in the laboratory diagnosis of the antiphospholipid syndrome.
    Decavele AS, Schouwers S, Devreese KM.
    Int J Lab Hematol; 2011 Feb; 33(1):97-108. PubMed ID: 20813022
    [Abstract] [Full Text] [Related]

  • 10. Real world experience with antiphospholipid antibody tests: how stable are results over time?
    Erkan D, Derksen WJ, Kaplan V, Sammaritano L, Pierangeli SS, Roubey R, Lockshin MD.
    Ann Rheum Dis; 2005 Sep; 64(9):1321-5. PubMed ID: 15731290
    [Abstract] [Full Text] [Related]

  • 11. Anticardiolipin and anti-beta2 glycoprotein I antibody concentrations in patients with type 2 diabetes mellitus.
    Tarkun I, Hacihanefioğlu A, Tarkun P, Cetinarslan B, Cantürk Z.
    Diabetes Res Clin Pract; 2005 Jun; 68(3):181-7. PubMed ID: 15936458
    [Abstract] [Full Text] [Related]

  • 12. Antiphospholipid antibodies among anti-U1-70 kDa autoantibody positive patients with mixed connective tissue disease.
    Komatireddy GR, Wang GS, Sharp GC, Hoffman RW.
    J Rheumatol; 1997 Feb; 24(2):319-22. PubMed ID: 9034990
    [Abstract] [Full Text] [Related]

  • 13. High titer of serum antiphospholipid antibody levels in adult Henoch-Schönlein purpura and cutaneous leukocytoclastic angiitis.
    Kawakami T, Yamazaki M, Mizoguchi M, Soma Y.
    Arthritis Rheum; 2008 Apr 15; 59(4):561-7. PubMed ID: 18383424
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Anti-beta2-glycoprotein I, anti-prothrombin and anticardiolipin antibodies in a longitudinal study of patients with systemic lupus erythematosus and the antiphospholipid syndrome.
    Inanç M, Donohoe S, Ravirajan CT, Radway-Bright EL, Mackie I, Machin S, Isenberg DA.
    Br J Rheumatol; 1998 Oct 15; 37(10):1089-94. PubMed ID: 9825748
    [Abstract] [Full Text] [Related]

  • 16. Prevalence and clinical significance of anti-phospholipid antibodies in multiple sclerosis: a study of 89 patients.
    Roussel V, Yi F, Jauberteau MO, Couderq C, Lacombe C, Michelet V, Gil R, Couratier P, Vallat JM, Preud'homme JL.
    J Autoimmun; 2000 May 15; 14(3):259-65. PubMed ID: 10756088
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Fatigue in patients with systemic lupus erythematosus: lack of associations to serum cytokines, antiphospholipid antibodies, or other disease characteristics.
    Omdal R, Mellgren SI, Koldingsnes W, Jacobsen EA, Husby G.
    J Rheumatol; 2002 Mar 15; 29(3):482-6. PubMed ID: 11908560
    [Abstract] [Full Text] [Related]

  • 19. Clinical manifestations of the antiphospholipid syndrome in patients with systemic lupus erythematosus associate more strongly with anti-beta 2-glycoprotein-I than with antiphospholipid antibodies.
    Cabiedes J, Cabral AR, Alarcón-Segovia D.
    J Rheumatol; 1995 Oct 15; 22(10):1899-906. PubMed ID: 8991989
    [Abstract] [Full Text] [Related]

  • 20. Anti-beta2 glycoprotein I antibodies and platelet activation in patients with antiphospholipid antibodies: association with increased excretion of platelet-derived thromboxane urinary metabolites.
    Forastiero R, Martinuzzo M, Carreras LO, Maclouf J.
    Thromb Haemost; 1998 Jan 15; 79(1):42-5. PubMed ID: 9459320
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.